Liu Liang-Chih, Lang Julie E, Jenkins Tyler, Lu Ying, Ewing Cheryl A, Hwang Shelley E, Sokol Shima, Alvarado Michael, Esserman Laura J, Morita Eugene, Treseler Patrick, Leong Stanley P
Department of Surgery and Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
J Am Coll Surg. 2008 Dec;207(6):853-8. doi: 10.1016/j.jamcollsurg.2008.08.008. Epub 2008 Oct 2.
No consensus exists about the number of sentinel lymph nodes (SLNs) that should be removed based on radioactivity counts in breast cancer, although the "10% rule" is often used. We hypothesized that the node with the highest radioactivity would have the strongest probability of being a positive SLN, and we sought to determine the lowest radioactive count of a node harboring cancer.
We retrospectively studied 332 breast cancer patients who underwent lymphoscintigraphy by injection of technetium 99m-labeled thiosulfate colloid and sentinel lymphadenectomy (SL) between 1997 and 2006, with intraoperative determination of radioactive counts of nodes by a gamma probe. All SLNs were examined by permanent sections consisting of at least 3 levels of 40- to 100-mum intervals for hematoxylin and eosin evaluation, with or without immunohistochemical staining for cytokeratins.
Seventy-four percent of patients had more than 1 SLN removed (mean 2.8 per patient); 23.5% had SLN metastasis. Of the node-positive patients, the hottest SLN was positive in 85.9% (67 of 78). Five of the 78 patients (6.4%) with positive nodes had counts less than 10% of those of the hottest node. The lowest radioactive count of a positive SLN was 4.2% of that of the hottest node. Lymphatic mapping based on the 10% rule could greatly improve the false-negative rates compared with removing only the hottest SLN (14.1% versus 6.4%).
Most positive SLNs had the highest radioactivity. Our institutional experience indicates that to obtain an acceptable false-negative rate, nodes should be removed until the 10% rule is met.
尽管“10%规则”经常被使用,但对于基于放射性计数应切除多少前哨淋巴结(SLN)用于乳腺癌治疗,目前尚无共识。我们假设放射性最高的淋巴结最有可能是阳性前哨淋巴结,并试图确定含有癌细胞的淋巴结的最低放射性计数。
我们回顾性研究了1997年至2006年间接受99m锝标记硫代硫酸盐胶体注射淋巴闪烁显像和前哨淋巴结切除术(SL)的332例乳腺癌患者,术中用γ探测器测定淋巴结的放射性计数。所有前哨淋巴结均通过至少3个水平、间隔40至100μm的永久切片进行苏木精和伊红染色评估,必要时进行细胞角蛋白免疫组化染色。
74%的患者切除了1个以上的前哨淋巴结(平均每位患者2.8个);23.5%有前哨淋巴结转移。在淋巴结阳性的患者中,放射性最高的前哨淋巴结阳性率为85.9%(78例中的67例)。78例淋巴结阳性患者中有5例(6.4%)的计数低于放射性最高淋巴结的10%。阳性前哨淋巴结的最低放射性计数为放射性最高淋巴结的4.2%。与仅切除放射性最高的前哨淋巴结相比,基于10%规则的淋巴绘图可大大提高假阴性率(14.1%对6.4%)。
大多数阳性前哨淋巴结放射性最高。我们机构的经验表明,为了获得可接受的假阴性率,应切除淋巴结直至符合10%规则。